Paul J Simmons

Title: Paul J Simmons: Innovator in Hematopoietic Stem Cell Research

Introduction

Paul J Simmons is a notable inventor based in Adelaide, Australia. He has made significant contributions to the field of hematopoietic stem cell research, holding 2 patents that showcase his innovative approaches.

Latest Patents

One of his latest patents is titled "Antibody 103B2," which is an antibody against peanut agglutinin-(PNA)-binding glycoprotein on the surface of cells. This antibody is registered at the German Collection of Microorganisms and Cell Cultures GmbH, DSMZ, under the Budapest Treaty. Another important patent is focused on "Methods of obtaining compositions enriched for hematopoietic stem cells." This method provides a novel approach for obtaining human hematopoietic stem cells by enriching for stem cells using a new stem cell marker. The compositions enriched for stem cells are obtained using a novel antibody, HCC-1, which is specific for a CD59 epitope that is highly accessible on stem cells and less accessible or absent on mature cells.

Career Highlights

Throughout his career, Paul has worked with several prominent organizations, including Systemix, Inc. and Eberhard-Karls-Universität Tübingen. His work has significantly advanced the understanding and application of stem cell technology.

Collaborations

Paul has collaborated with notable colleagues, including Beth Louis Hill and Benjamin P Chen, contributing to various research initiatives and projects.

Conclusion

Paul J Simmons is a distinguished inventor whose work in hematopoietic stem cell research has led to valuable patents and collaborations. His innovative contributions continue to impact the field significantly.